Lexaria Bioscience Corp. (LEXX)

0.6098 -0.03 (-4.82%) USD  |  NASDAQ  |  May 08, 16:00
0.63 +0.02 (+3.31%) After-Hours: 20:00
More

Lexaria Bioscience EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
CannaPharmaRx, Inc. Upgrade
InMed Pharmaceuticals, Inc. Upgrade
Target Group, Inc. (Canada) Upgrade
Tilray Brands, Inc. Upgrade
NervGen Pharma Corp. Upgrade